This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Fiber-specific micro- and macroscopic white matter alterations in progressive supranuclear palsy and corticobasal syndrome
npj Parkinson's Disease Open Access 17 August 2023
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Nath U et al. (2001) The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain 124: 1438–1449
Burn DJ and Lees AJ (2002) Progressive supranuclear palsy: where are we now? Lancet Neurol 1: 359–369
Scatena R et al. (2007) An update on pharmacological approaches to neurodegenerative diseases. Expert Opin Investig Drugs 16: 59–72
Williams DR et al. (2005) Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 128: 1247–1258
Schrag A et al. (2006) Measuring quality of life in PSP: the PSP-QoL. Neurology 67: 39–44
Acknowledgements
The synopsis was written by Martina Habeck, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Burn, D. Clinical assessment of progressive supranuclear palsy over time: new rating scale validated. Nat Rev Neurol 3, 600–601 (2007). https://doi.org/10.1038/ncpneuro0603
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpneuro0603
This article is cited by
-
Fiber-specific micro- and macroscopic white matter alterations in progressive supranuclear palsy and corticobasal syndrome
npj Parkinson's Disease (2023)